Cargando…
Dataset on granulopoiesis- and lymphopoiesis-stimulating cytokine levels in insulin secretagogue users with incident breast cancer
GM-CSF and G-CSF are widely used for their benefit in reducing chemotherapy-associated neutropenia. However, whether GM- or G-CSF administration could have tumorigenic or pro-metastatic effects or whether insulin resistance could negatively impact such effects is not known. Their ability to stimulat...
Autores principales: | Wintrob, Zachary A.P., Hammel, Jeffrey P., Nimako, George K., Gaile, Dan P., Forrest, Alan, Ceacareanu, Alice C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328709/ https://www.ncbi.nlm.nih.gov/pubmed/28275660 http://dx.doi.org/10.1016/j.dib.2017.02.027 |
Ejemplares similares
-
TH1 and TH2 cytokine data in insulin secretagogues users newly diagnosed with breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017) -
Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017) -
TH1 and TH2 cytokines dataset in insulin users with diabetes mellitus and newly diagnosed breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017) -
Circulating adipokines data associated with insulin secretagogue use in breast cancer patients
por: Wintrob, Zachary A.P., et al.
Publicado: (2016) -
Insulin secretagogue use and circulating inflammatory C–C chemokine levels in breast cancer patients
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)